Largazole is a Brain-Penetrant Class I HDAC Inhibitor with Extended Applicability to Glioblastoma and CNS Diseases

MLA

Ranjala Ratnayake, et al. “Largazole Is a Brain-Penetrant Class I HDAC Inhibitor with Extended Applicability to Glioblastoma and CNS Diseases.” ACS Chemical Neuroscience, vol. 11, June 2020, pp. 1937–43. EBSCOhost, https://doi.org/10.1021/acschemneuro.0c00093.

APA

Ranjala Ratnayake, Lobna A. Elsadek, Lilibeth A. Salvador-Reyes, Fatma H. Al-Awadhi, Qi-Yin Chen, & Hendrik Luesch. (2020). Largazole is a Brain-Penetrant Class I HDAC Inhibitor with Extended Applicability to Glioblastoma and CNS Diseases. ACS Chemical Neuroscience, 11, 1937–1943. https://doi.org/10.1021/acschemneuro.0c00093

Chicago

Ranjala Ratnayake, Lobna A. Elsadek, Lilibeth A. Salvador-Reyes, Fatma H. Al-Awadhi, Qi-Yin Chen, and Hendrik Luesch. 2020. “Largazole Is a Brain-Penetrant Class I HDAC Inhibitor with Extended Applicability to Glioblastoma and CNS Diseases.” ACS Chemical Neuroscience 11 (June): 1937–43. doi:10.1021/acschemneuro.0c00093.